Ordering
Available Variants250 μg
CHA.18777-250μg
Price
€251.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 μg | CHA.18777-250μg | €251.20 |
From Neosartorya fischeri, breast cancer restance protein inhibitor, film
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C22H25N3O3 |
|---|---|
| CAS Number | 118974-02-0 |
| Molecular Weight | 379.45 |
| UNSPSC Code | 12161501 |
| PubChem Substance ID | 24724486 |
| NACRES | NA.77 |
| MDL number | MFCD08702652 |
| Form | film |
| Quality level | 200 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Fumitremorgin C, with a CAS number of 118974-02-0, is a naturally occurring compound that has garnered significant attention in the scientific community due to its potential therapeutic applications. This tremorgenic mycotoxin, produced by certain species of fungi, exhibits a unique mechanism of action that has been found to inhibit the breast cancer resistance protein, a key efflux transporter involved in multidrug resistance. As a result, fumitremorgin C has been investigated as a potential chemosensitizer, with studies demonstrating its ability to enhance the efficacy of various anticancer agents. Further research is needed to fully elucidate the pharmacological properties and potential clinical utility of fumitremorgin C, but its unique biological profile makes it an intriguing candidate for the development of novel cancer therapies. Its chemical structure and properties are being extensively studied to explore its potential benefits.
